Browsing by Author deFazio, Anna

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 61  next >
Issue DateTitleAuthor(s)Citation
2014ABCA transporter gene expression and poor outcome in epithelial ovarian cancerdeFazio, Anna; Emmanuel, Catherine; Gao, Bo; Harnett, Paul; Beesley, Johnathan; Chen, Xiaoqing; et al, Various; Flemming, Claudia L.; George, Joshy; Hedditch, Ellen; Johnatty, Sharon E.; Li, Yi; Russell, Amanda; Study Group, Australian Ovarian Cancer; William, Rebekka T; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Medicine (Westmead)ABCA transporter gene expression and poor outcome in epithelial ovarian cancer, Journal of the National Cancer Institute, vol.106, 7, 2014,pp 1-11
2008ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapydeFazio, Anna; Harnett, Paul; AOCS, Study Group; Beesley, Johnathan; Brown, Robert; Byth, Karen; Chenevix-Trench, Georgia; Fereday, Sian; Johnatty, Sharon E.; Marsh, Sharon; McLeod, Howard; Paul, Jim; Spurdle, Amanda B.; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy, Clinical Cancer Research, vol.14, 17, 2008,pp 5594-5601
2013ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasdeFazio, Anna; Emmanuel, Catherine; Gao, Bo-Fu; Beesley, Johnathan; Chen, Xiaoqing; et al, Various; Fereday, Sian; Hedditch, Ellen; Henderson, Michelle; Johnatty, Sharon E.; Law, Matthew; Lu, Yi; Russell, Amanda; Webb, Penelope M.; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas, Gynecologic Oncology, vol.131, 1, 2013,pp 8-14
2013Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer OutcomedeFazio, Anna; Block, Matthew; Charbonneau, Bridget; Chenevix-Trench, Georgia; Cramer, Daniel; et al, Various; Fogarty, Zachary; Pearce, C Leigh; Pharoah, Paul D. P.; Rossing, Mary Anne; Vierkant, Robert; White, Kristin; Western Clinical School: Westmead Millennium InstituteAnalysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome, Cancer Epidemiology, Biomarkers and Prevention, vol.22, 5, 2013,pp 987-992
2008Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerBalleine, Rosemary; Chiew, Yoke-Eng; deFazio, Anna; Guminski, Alexander; Harnett, Paul; Kennedy, Catherine Jane; Lei, Ying; Pryor, Kylie; Rizos, Helen; Scurr, Lyndee; Brand, Alison; Byth, Karen; Sharma, Raghwa; Wain, Gerard V.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer, Clinical Cancer Research, vol.14, 21, 2008,pp 6924-6932
2015Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survivaldeFazio, Anna; Ibiebele, T; Nagle, Christina M.; Protani, Melinda; Webb, Penelope M.; Western Clinical School: Westmead Institute for Medical ResAspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival, Cancer Epidemiology, vol.39, 2, 2015,pp 196-199
2016Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factorsdeFazio, Anna; Anton-Culver, Hoda; Chang-Claude, Jenny; et al, Various; McGuire, Valerie; Raghavan, Rama; Rudolph, Anja; Sieh, Weiva; Tyrer, Johnathan; Usset, Joseph L; Webb, Penelope M.; Western Clinical School: Westmead Institute for Medical ResAssessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors, Cancer Epidemiology, Biomarkers and Prevention, vol.25, 5, 2016,pp 780-790
2015The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic functionBrodie, Kirsty Maree; deFazio, Anna; Henderson, Beric; Lei, Ying; Martino-Echarri, Estefania; Marzec, Kamila; Mills, Kate; Mok, Myth; Rizos, Helen; Tembe, Varsha; Boadle, Ross; Kettle, Emma; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Medicine; Western Clinical School: Westmead Institute for Medical Res; Research Grants and Contracts; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResThe BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function, Cellular Signalling, vol.27, 9, 2015,pp 1763-1771
2012BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Emmanuel, Catherine; Alsop, Kathryn; Birrer, Michael; Bowtell, David D L; Dobrovic, Alexander; Fereday, Sian; Fox, Stephen B.; Friedlander, Michael; George, Joshy; Meldrum, Cliff; Mitchell, Gillian; Stewart, Colin; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteBRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.30, 21, 2012,pp 2654-2663
2014Caring for women with ovarian cancer in the last year of life: A longitudinal study of caregiver quality of life, distress and unmet needsBell, Melanie Lynn; Butow, Phyllis; deFazio, Anna; Friedlander, Michael; Price, Melanie; Webb, Penelope M; Psychology; Psychology; Western Clinical School: Westmead Millennium Institute; School of Public Health: NH&MRC Clinical Trials Centre; PsychologyCaring for women with ovarian cancer in the last year of life: A longitudinal study of caregiver quality of life, distress and unmet needs, Gynecologic Oncology, vol.132, 3, 2014,pp 690-697
2016Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancerdeFazio, Anna; Kennedy, Catherine; Adams, Mark N; Beaven, Elizabeth A; Chetty, Naven P; Crandon, Alexander J; Davies, Claire M; et al, Various; Harrington, Brittney S; he, Yaowu; Roche, Deborah K; Wallace, Sarah J; Western Clinical School: Westmead Institute for Medical Res; Central Clinical School: SurgeryCell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer, British Journal of Clinical Pharmacology, vol.114, 4, 2016,pp 417-426
2015Circulating 25-hydroxyvitamin D and survival in women with ovarian cancerBrand, Alison; deFazio, Anna; Blomfield, Penelope; Grant, Peter Thomas; Ibiebele, T; Nagle, Christina M.; Neale, Rachel E; Perrin, Lewis; Protani, Melinda; Webb, Penelope M.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteCirculating 25-hydroxyvitamin D and survival in women with ovarian cancer, The American Journal of Clinical Nutrition, vol.102, 1, 2015,pp 109-114
2011Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian CancersdeFazio, Anna; Anglesio, Michael S.; Cowin, Prue; et al, various; Etemadmoghadam, Dariush; George, Joshy; Helland, Aslaug; House, Colin; Johnstone, Cameron; Melnyk, Nataliya; Rustgi, Anil K.; Sheppard, Karen; Western Clinical School: Westmead Millennium InstituteDeregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers, PLoS One, vol.6, 4, 2011,pp Article number e18064-1-Article number e18064-9
2014Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survivaldeFazio, Anna; Gard, Greg; Beesley, Johnathan; Crandon, Alex; Dixon, S; Ibiebele, T; Nagle, Christina M.; Protani, Melinda; Rome, Robert; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: Obstetrics & GynaecologyDietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival, Gynecologic Oncology, vol.132, 3, 2014,pp 566-572
2010DNA of mouse mammary tumor virus-like virus is present in human tumors influenced by hormonesdeFazio, Anna; Cozzi, Paul J.; Faedo, Margaret; Faltas, Jacqueline; Johal, Harpreet; Lau, Amie; Mousina, Railya; Rawlinson, William; Western Clinical School: Westmead Millennium InstituteDNA of mouse mammary tumor virus-like virus is present in human tumors influenced by hormones, Journal of Medical Virology, vol.82, 6,pp 1044-1050
2010Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.deFazio, Anna; Sharma, Raghwa; Ahmed Ashoure, Ahmed; Bowtell, David D L; Brenton, James D; Caldas, Carlos; Etemadmoghadam, Dariush; Fereday, Sian; Lynch, Andy; Riad, Mohamed; Stewart, Colin L.; Temple, Jillian; Western Clinical School: Westmead Millennium Institute; MedicineDriver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary., Journal of Pathology, vol.221, 1,pp 49-56
2010Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"deFazio, Anna; Gava, Natalie; Beesley, Johnathan; Chen, Xiaoqing; Doherty, Jennifer Anne; Duffy, D. L.; et al, various; Johnatty, Sharon E.; MacGregor, Stuart; Rossing, Mary Anne; Spurdle, Amanda B; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot", PLoS Genetics, vol.6, 7,pp e1001016 - 1-e1001016 - 10
2014Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studydeFazio, Anna; Madore, Jason; Bowtell, David D L; Clarke, B; Deen, Suha; et al, Various; Kobel, M; Lele, S; Menon, U; Morrison, C; Odunsi, Kunle; Pharoah, Paul D. P.; Ramus, Susan J.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study, British Journal of Cancer, vol.111, 12, 2014,pp 2297-2307
2014Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulationdeFazio, Anna; Cowper-Sal-lari, Richard; Desai, Kinjal; Edwards, Stacey; et al, Various; Ghoussaini, Maya; Glubb, Dylan M; Hillman, Kristine M; Kar, Siddhartha; Kaufmann, Susanne; Michailidou, Kyriaki; Nord, Silje; Western Clinical School: Westmead Millennium InstituteEvidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation, Nature Communications, vol.4, N/A, 2014,pp 1-12
2004Expression Of Progesterone Receptor A And B Isoforms In Low-Grade Endometrial Stromal Sarcoma.Balleine, Rosemary; Clarke, Christine; deFazio, Anna; Earls, Peter; Harnett, Paul; Mote, Patricia; Webster, Lucy; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteExpression Of Progesterone Receptor A And B Isoforms In Low-Grade Endometrial Stromal Sarcoma., International Journal of Gynecological Pathology, vol.23,(2),2004,pp 138-144